Can Our Hair Reveal Breast CAncer?

Could hair tests someday provide a viable alternative to mammograms? An Australian research consortium is exploring the possibility after discovering that hair from women with breast cancer had a different cell structure to hair from women without the disease.

The technology being tested is a synchrotron particle accelerator, an x-ray machine that bombards hair strands (rather than our breasts) with x-rays. The pattern produced by the x-rays is described as a series of arcs, while in people with breast cancer a distinctive ring is superimposed on top of the arcs.

It turns out that the first published study reporting this promising technology was back in 1999, in the journal Nature. Unfortunately, other researchers were unable to reproduce the results and so the work continued. Since then, the original authors have determined that other researchers were unable to reproduce their results either because they were using hair damaged by dyes or other chemicals, or because hairs were either stretched or wrongly aligned under the beam.

An especially interesting finding in that original study was that all the hair samples from women who tested positive for a mutation of the BRCA1 gene, showed the same hair changes as those with breast cancer.

Some might be inclined to dismiss such research as pie-in-the-sky thinking, but my guess is that this is no more pie-in-the-sky than dreaming the breast cancer vaccine. I’ll happily eat my pie in the sky! Have you ever heard about this promising test?

Susan Beausang, 4Women.com

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap